Posted by undopaminergic on October 8, 2021, at 11:00:48
In reply to Re: Real World data and new drugs, posted by SLS on October 7, 2021, at 18:06:48
> >
> > Money? Isn't there more money to be made from showing efficacy of the drug? So, they would want to choose subjects that will respond better to the drug, wouldn't they?
> >
> > -undopaminergic
>
>
> UD,
>
> The clinical trial company gets paid by the number of subjects they recruit. They really don't give a damn whether the drug works or not, as long as they get paid and their contract renewed.
>
> -----
>
> Prospective participant: "I'm depressed."
>
> Screening coordinator: "Okay. That's good enough. You are definitely eligible for our study. Just sign this paper."
>
> -----
>OK, but the sponsoring pharmaceutical company *does* give a damn whether their drug gets approved, so why would they hire a clinical trial company that does not maximise the chance of approval?
-undopaminergic
poster:undopaminergic
thread:1117173
URL: http://www.dr-bob.org/babble/20210723/msgs/1117190.html